Literature DB >> 11874884

Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood.

Mariko Yoshida1, Sadayoshi Torigoe, Kumiko Ikeue, Masao Yamada.   

Abstract

Seroprevalence of human herpesvirus 6 (HHV-6) and HHV-7 infections is very high throughout the world, and almost all people are exposed first to HHV-6 and second to HHV-7 in their childhood. However, it is not clear whether the neutralizing (NT) antibody response between each virus is cross-reactive or not. To elucidate the NT antibody response between each virus, 55 serum samples from an adult group (subjects 22 to 88 years old) and 60 serum samples from a young group (subjects 2 to 18 years old) were examined by a dot blot method for detecting viral late antigen. Thirty-nine serum samples obtained from cord bloods and a few serum samples obtained from pediatric patients with exanthem subitum were also examined to assess the maternal transferred NT antibodies against each virus. The NT antibody titers against HHV-7 in the adult group remained high throughout all the individuals, and none were negative. Those against HHV-6 were high values in the young group but low values, including negative values (three samples), in the adult group. These results suggested that the NT antibody response to either HHV-6 or HHV-7 in each individual was specific to each virus and did not cross-react with each other. In the adult group, the NT antibody response to HHV-6 decreased, while that to HHV-7 remained high throughout all the individuals. Maternal transferred NT antibody titers against HHV-7 were higher and remained longer after birth than those of HHV-6, and these findings were in accord with the clinical observation that HHV-6 infection usually occurs earlier than HHV-7 infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874884      PMCID: PMC119946          DOI: 10.1128/cdli.9.2.388-393.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

Review 1.  Childhood infections with human herpesviruses types 6, 7, and 8.

Authors:  C Grose
Journal:  Adv Pediatr Infect Dis       Date:  1996

Review 2.  Three new human herpesviruses (HHV6, 7, and 8).

Authors:  J A Levy
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

3.  Transmission of human herpesvirus 7 through multigenerational families in the same household.

Authors:  Y Takahashi; M Yamada; J Nakamura; T Tsukazaki; J Padilla; T Kitamura; M Yoshida; S Nii
Journal:  Pediatr Infect Dis J       Date:  1997-10       Impact factor: 2.129

4.  Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome.

Authors:  V Descamps; F Bouscarat; S Laglenne; E Aslangul; B Veber; D Descamps; J L Saraux; M J Grange; M Grossin; E Navratil; B Crickx; S Belaich
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

5.  Frequent isolation of human herpesvirus 7 from saliva.

Authors:  J B Black; N Inoue; K Kite-Powell; S Zaki; P E Pellett
Journal:  Virus Res       Date:  1993-07       Impact factor: 3.303

6.  Frequent isolation of human herpesvirus 7 from saliva samples.

Authors:  Y Hidaka; Y Liu; M Yamamoto; R Mori; C Miyazaki; K Kusuhara; K Okada; K Ueda
Journal:  J Med Virol       Date:  1993-08       Impact factor: 2.327

7.  A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.

Authors:  M Yoshida; M Yamada; S Chatterjee; F Lakeman; S Nii; R J Whitley
Journal:  J Virol Methods       Date:  1996-04-26       Impact factor: 2.014

8.  Human herpesvirus 7: another causal agent for roseola (exanthem subitum).

Authors:  K Tanaka; T Kondo; S Torigoe; S Okada; T Mukai; K Yamanishi
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

9.  Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome.

Authors:  Y Suzuki; R Inagi; T Aono; K Yamanishi; T Shiohara
Journal:  Arch Dermatol       Date:  1998-09

10.  Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.

Authors:  P B Challoner; K T Smith; J D Parker; D L MacLeod; S N Coulter; T M Rose; E R Schultz; J L Bennett; R L Garber; M Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  3 in total

1.  High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China.

Authors:  Y Cao; V Minhas; X Tan; J Huang; B Wang; M Zhu; Y Gao; T Zhao; L Yang; C Wood
Journal:  Clin Microbiol Infect       Date:  2013-08-28       Impact factor: 8.067

2.  Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies.

Authors:  Mariko Yoshida; Sadayoshi Torigoe; Masao Yamada
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

3.  Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.

Authors:  Jun Zheng; Yang Yang; Meng Cui; Zhan-Jun Shu; Li-Li Han; Zhen-Qiu Liu; Charles Wood; Tiejun Zhang; Yan Zeng
Journal:  Virol Sin       Date:  2017-10-25       Impact factor: 4.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.